Chewy tells one story. Your DTC tells another. Your vet partners hear a third. Every inconsistency erodes the trust pet parents demand.
CAC is climbing, LTV is uncertain, and 40% of subscribers cancel within 60 days. Your growth team is optimizing for cheaper customers, not better ones.
Your growth team doesn't talk to vets. Your influencers amplify claims you haven't verified. Clinical credibility is everything in pet health, and it's eroding.
Subscription economics — LTV:CAC, 30/60/90-day churn cliff analysis
Vet endorsement dynamics and AAFCO claims compliance
Multi-channel cohort analysis (Chewy vs. DTC vs. vet channel LTV)
Retention-first experimentation (reorder rate, NPS, clinical trust)
Telehealth integration and embedded vet credibility
Goal: Proving LTV:CAC before scaling acquisition
Goal: Keeping churn flat while acquisition grows
Goal: Scaling clinical credibility alongside DTC channels
Diagnostics, frameworks, and playbooks built for pet health dtc operators.
Your growth team doesn't talk to vets. Your influencers amplify claims you haven't verified. Here's how to make clinical credibility your cheapest acquisition channel.
DownloadYour DTC site says one thing. Your Amazon listing says another. Your vet channel says a third. This diagnostic finds every fracture point.
DownloadYour subscribers aren't leaving because of your product. They're leaving because of when you ask them to believe.
DownloadA systematic architecture that transforms experimentation from an activity into a strategic asset.
We map every experiment against strategic priorities, margin targets, and brand equity. Nothing runs without a reason.
We design an experimentation roadmap that drives profit, not activity. Every test has a strategic hypothesis tied to business outcomes.
We embed with your team to execute, measure, and scale what works. Profit-validated growth, compounding quarter over quarter.
Get a strategic diagnostic built for pet health dtc operators. We'll audit your experimentation program and show you where the leverage is.